Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2012 1
2013 2
2014 2
2015 1
2016 2
2017 2
2018 2
2019 3
2020 2
2021 1
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic Protein Drug Interactions: A White Paper From the International Consortium for Innovation and Quality in Pharmaceutical Development.
Coutant DE, Boulton DW, Dahal UP, Deslandes A, Grimaldi C, Pereira JNS, Säll C, Sarvaiya H, Schiller H, Tai G, Umehara K, Yuan Y, Dallas S. Coutant DE, et al. Among authors: schiller h. Clin Pharmacol Ther. 2023 Jun;113(6):1185-1198. doi: 10.1002/cpt.2814. Epub 2023 Jan 17. Clin Pharmacol Ther. 2023. PMID: 36477720 Review.
Industry Perspective on Therapeutic Peptide Drug-Drug Interaction Assessments During Drug Development: A European Federation of Pharmaceutical Industries and Associations White Paper.
Säll C, Argikar U, Fonseca K, Hilgendorf C, Lopes F, Riedel J, Schiller H, Sonesson A, Umehara K, Wang K. Säll C, et al. Among authors: schiller h. Clin Pharmacol Ther. 2023 Jun;113(6):1199-1216. doi: 10.1002/cpt.2847. Epub 2023 Jan 31. Clin Pharmacol Ther. 2023. PMID: 36633114 Review.
The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease.
Neumann U, Ufer M, Jacobson LH, Rouzade-Dominguez ML, Huledal G, Kolly C, Lüönd RM, Machauer R, Veenstra SJ, Hurth K, Rueeger H, Tintelnot-Blomley M, Staufenbiel M, Shimshek DR, Perrot L, Frieauff W, Dubost V, Schiller H, Vogg B, Beltz K, Avrameas A, Kretz S, Pezous N, Rondeau JM, Beckmann N, Hartmann A, Vormfelde S, David OJ, Galli B, Ramos R, Graf A, Lopez Lopez C. Neumann U, et al. Among authors: schiller h. EMBO Mol Med. 2018 Nov;10(11):e9316. doi: 10.15252/emmm.201809316. EMBO Mol Med. 2018. PMID: 30224383 Free PMC article. Clinical Trial.
Aldehyde oxidase activity in fresh human skin.
Manevski N, Balavenkatraman KK, Bertschi B, Swart P, Walles M, Camenisch G, Schiller H, Kretz O, Ling B, Wettstein R, Schaefer DJ, Pognan F, Wolf A, Litherland K. Manevski N, et al. Among authors: schiller h. Drug Metab Dispos. 2014 Dec;42(12):2049-57. doi: 10.1124/dmd.114.060368. Epub 2014 Sep 23. Drug Metab Dispos. 2014. PMID: 25249692
Assessment of the pulmonary CYP1A1 metabolism of mavoglurant (AFQ056) in rat.
Yilmaz Y, Umehara K, Williams G, Faller T, Schiller H, Walles M, Kraehenbuehl S, Camenisch G, Manevski N. Yilmaz Y, et al. Among authors: schiller h. Xenobiotica. 2018 Aug;48(8):793-803. doi: 10.1080/00498254.2017.1373311. Epub 2017 Sep 29. Xenobiotica. 2018. PMID: 28879796
The potential of Sutherlandia frutescens for herb-drug interaction.
Fasinu PS, Gutmann H, Schiller H, James AD, Bouic PJ, Rosenkranz B. Fasinu PS, et al. Among authors: schiller h. Drug Metab Dispos. 2013 Feb;41(2):488-97. doi: 10.1124/dmd.112.049593. Epub 2012 Dec 3. Drug Metab Dispos. 2013. PMID: 23209194
21 results